학술논문

Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
Document Type
Article
Source
In: Cancer immunology research. (Cancer immunology research, 2 December 2022, 10(12):1441-1461)
Subject
Language
English
ISSN
23266074